These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 12140559
1. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. Nature; 2002 Jul 25; 418(6896):422-5. PubMed ID: 12140559 [Abstract] [Full Text] [Related]
3. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F. Hum Mol Genet; 2003 Nov 01; 12(21):2853-61. PubMed ID: 12966029 [Abstract] [Full Text] [Related]
4. Full circle to cobbled brain. Ross ME. Nature; 2002 Jul 25; 418(6896):376-7. PubMed ID: 12140540 [No Abstract] [Full Text] [Related]
5. [Dystroglycan linkage and muscular dystrophy]. Shimizu T. Rinsho Shinkeigaku; 2002 Nov 25; 42(11):1091-4. PubMed ID: 12784674 [Abstract] [Full Text] [Related]
6. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK, Hewitt JE. Hum Mol Genet; 2003 Oct 15; 12 Spec No 2():R259-64. PubMed ID: 12925572 [Abstract] [Full Text] [Related]
11. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Matsumura K, Campbell KP. Muscle Nerve; 1994 Jan 15; 17(1):2-15. PubMed ID: 8264699 [Abstract] [Full Text] [Related]
12. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy. Toda T, Kobayashi K, Takeda S, Sasaki J, Kurahashi H, Kano H, Tachikawa M, Wang F, Nagai Y, Taniguchi K, Taniguchi M, Sunada Y, Terashima T, Endo T, Matsumura K. Congenit Anom (Kyoto); 2003 Jun 15; 43(2):97-104. PubMed ID: 12893968 [Abstract] [Full Text] [Related]
14. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Langenbach KJ, Rando TA. Muscle Nerve; 2002 Nov 15; 26(5):644-53. PubMed ID: 12402286 [Abstract] [Full Text] [Related]
15. Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains. Saito Y, Yamamoto T, Mizuguchi M, Kobayashi M, Saito K, Ohno K, Osawa M. Brain Res; 2006 Feb 23; 1075(1):223-8. PubMed ID: 16466646 [Abstract] [Full Text] [Related]
16. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Martin PT. Glycobiology; 2003 Aug 23; 13(8):55R-66R. PubMed ID: 12736199 [Abstract] [Full Text] [Related]
17. Effects of fukutin deficiency in the developing mouse brain. Chiyonobu T, Sasaki J, Nagai Y, Takeda S, Funakoshi H, Nakamura T, Sugimoto T, Toda T. Neuromuscul Disord; 2005 Jun 23; 15(6):416-26. PubMed ID: 15907289 [Abstract] [Full Text] [Related]
19. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. Sciandra F, Bozzi M, Bianchi M, Pavoni E, Giardina B, Brancaccio A. Ann Ist Super Sanita; 2003 Jun 23; 39(2):173-81. PubMed ID: 14587215 [Abstract] [Full Text] [Related]